Head-to-head · The Match Score
ShedRx vs GetRelief Rx
Both scored on the same six-factor Match Score. ShedRx wins this matchup with a 86 to 64 edge.
ShedRx
#4 · Grade B+
People who want an oral or sublingual option rather than weekly injections.
Visit ShedRxGetRelief Rx
#222 · Grade C
People who want sublingual (non-injectable) compounded GLP-1 drops for the needle-averse.
Visit GetRelief RxFactor by factor
The six sub-scores behind each Match Score. The quiz reweights these to your priorities — one provider can pull ahead for you on the factors you care about.
Price, coverage & formulary
| Detail | ShedRx | GetRelief Rx |
|---|---|---|
| Semaglutide | $199/mo | $269/mo (9 mg dose, compounded oral) |
| Tirzepatide | $299/mo | $179/mo (16 mg dose, compounded oral) |
| Coverage | All 50 states | Coverage not published |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Yes | Yes |
| Match Score | 86 · B+ | 64 · C |
ShedRx edges out GetRelief Rx, 86 to 64 on the default Match Score. A weight-focused program that also offers an oral/sublingual route for the needle-averse.
GetRelief Rx is still a fair pick if its strengths line up with yours — best for: People who want sublingual (non-injectable) compounded GLP-1 drops for the needle-averse.
Worth a look either way: our overall #1 pick is CoreAge Rx (Match Score 91) — nationwide access, both molecules at one flat price, easy to cancel. Or take the 6-question quiz to see your personalized match.
Assume any provider we list may compensate us, at no cost to you. It never changes the Match Score.
More head-to-heads
- ShedRx vs CoreAge Rx
- ShedRx vs Strut Health
- ShedRx vs Ondra Health
- ShedRx vs Enhance MD
- ShedRx vs Eden
- ShedRx vs Vaylen
Or browse alternatives to ShedRx and all comparisons.
Pricing, states and verification reflect each provider's public disclosures at last review; the Match Score and its sub-scores are our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.